Kanamori Akira, Kiriyama Seiki, Tanikawa Makoto, Hisanaga Yasuhiro, Toyoda Hidenori, Tada Toshifumi, Kitabatake Syusuke, Kaneoka Yuji, Maeda Atsuyuki, Kumada Takashi
Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Department of Surgery, Ogaki Municipal Hospital, Ogaki, Japan.
Endosc Int Open. 2016 Jan;4(1):E83-90. doi: 10.1055/s-0041-108194. Epub 2015 Dec 15.
Backgrounds and study aims: Endoscopic sphincterotomy (ES) is widely accepted as first-line therapy for bile duct stones (BDS). The major long-term pancreaticobiliary complication is BDS recurrence. Whether cholecystectomy should be performed after ES, especially in elderly patients, remains controversial. The aim of this study is to investigate the short-term and long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography (ERCP) for BDS and to analyze risk factors for pancreaticobiliary complications. We also compared long-term outcomes in patients older and younger than age 80.
A total of 1210 patients who underwent therapeutic ERCP for BDS were retrospectively reviewed to identify risk factors for pancreaticobiliary complications. We divided these patients into two groups: Group Y (< 80 years; 960 patients) and Group O (≥ 80 years; 250 patients). There were 192 matched pairs in the propensity score analysis.
The incidence of pancreaticobiliary complications was 13.1 % (126/960) in Group Y and 20.4 % (51/250) in Group O (P < 0.00001). Multivariate analysis showed that a gallbladder left in situ with stones was a significant independent risk factor (hazard ratio, 2.81; 95 % confidence interval, 1.62 - 4,89; P = 0.0002). There were no significant differences in the incidence of pancreaticobiliary complications between the propensity score-matched groups.
A gallbladder in situ with stones was the only significant risk factor for pancreaticobiliary complications after treatment for BDS. Age per se should not be the major factor when deciding on treatment that minimizes the occurrence of pancreaticobiliary disease.
背景与研究目的:内镜括约肌切开术(ES)被广泛接受为胆管结石(BDS)的一线治疗方法。主要的长期胰胆并发症是BDS复发。ES术后是否应行胆囊切除术,尤其是老年患者,仍存在争议。本研究的目的是调查治疗性内镜逆行胰胆管造影术(ERCP)治疗BDS后的短期和长期结局,并分析胰胆并发症的危险因素。我们还比较了80岁及以上和80岁以下患者的长期结局。
对1210例行治疗性ERCP治疗BDS的患者进行回顾性分析,以确定胰胆并发症的危险因素。我们将这些患者分为两组:Y组(<80岁;960例患者)和O组(≥80岁;250例患者)。倾向评分分析中有192对匹配对。
Y组胰胆并发症发生率为13.1%(126/960),O组为20.4%(51/2)50)(P<0.00001)。多因素分析显示,胆囊结石残留是一个显著的独立危险因素(风险比,2.81;95%置信区间,1.62 - 4.89;P = 0.0002)。倾向评分匹配组之间胰胆并发症发生率无显著差异。
胆囊结石残留是BDS治疗后胰胆并发症的唯一显著危险因素。在决定采取何种治疗以尽量减少胰胆疾病发生时,年龄本身不应是主要因素。